机译:乙型肝炎病毒再激活和随后肝炎患者慢性丙型肝炎接受直接作用抗病毒治疗的肝炎发病率低
Department of HepatologyOsaka City University Graduate School of MedicineOsaka Japan;
Clinical Research CenterNational Hospital OrganizationOmura Japan;
Division of Hepatobiliary and Pancreatic DiseaseHyogo College of MedicineNishinomiya Japan;
Department of HepatologyOsaka City General HospitalOsaka Japan;
The Research Center for Hepatitis and ImmunologyNational Center for Global Health and;
Department of Gastroenterology and Neurology Faculty of MedicineKagawa UniversityKagawa Japan;
Department of HepatologyOsaka City University Graduate School of MedicineOsaka Japan;
Genome Medical Sciences ProjectNational Center for Global Health and MedicineIchikawa Japan;
Department of Gastroenterology and Neurology Faculty of MedicineKagawa UniversityKagawa Japan;
Department of HepatologyOsaka City University Graduate School of MedicineOsaka Japan;
Clinical Research CenterNational Hospital OrganizationOmura Japan;
Division of Hepatobiliary and Pancreatic DiseaseHyogo College of MedicineNishinomiya Japan;
Genome Medical Sciences ProjectNational Center for Global Health and MedicineIchikawa Japan;
antihepatitis B surface antigen; direct‐acting antiviral agents; hepatitis B virus; hepatitis C virus; reactivation;
机译:乙型肝炎病毒再激活和随后肝炎患者慢性丙型肝炎接受直接作用抗病毒治疗的肝炎发病率低
机译:乙型肝炎病毒再激活和随后肝炎患者慢性丙型肝炎接受直接作用抗病毒治疗的肝炎发病率低
机译:慢性丙型肝炎接受直接作用抗病毒治疗患者HBV再激活和随后的肝炎发生率低
机译:MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
机译:通过直接作用抗病毒治疗,在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢,炎症和免疫参数随时间随时间的分布,通过直接作用抗病毒治疗治愈丙型肝炎病毒
机译:接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
机译:编辑:乙型肝炎重新激活患者慢性丙型肝炎患者治疗直接作用抗病毒治疗 - 发病率,肝炎严重程度和学习的教训